ORIGINAL RESEARCH
A Prospective 12-week Randomized Controlled Trial of Remotely-Delivered Customized Adherence Enhancement for Poorly Adherent Individuals with Schizophrenia vs Enhanced Treatment as Usual
Objective: This prospective 12-week randomized controlled trial tested an adherence promotion approach called Customized Adherence Enhancement in schizophrenia (CAE-S) vs. Enhanced Treatment as Usual (eTAU) in 36 poorly adherent individuals. Methods: Patients were randomized to...